Amendment to Blood Screening Products Agreement between Chiron Corporation and Gen-Probe Incorporated (December 7, 1999)

Contract Categories: Business Finance › Modification Agreements
Summary

Chiron Corporation and Gen-Probe Incorporated have agreed to amend their original June 11, 1998 agreement regarding products for blood screening. This amendment specifically revises Article 14, detailing new payment terms from Chiron to Gen-Probe for certain rights related to TMA and HPA technologies. All other terms of the original agreement remain unchanged. The amendment is effective as of December 7, 1999, and is signed by authorized representatives of both companies.

Read More Arrow
EX-10.313 6 a2039414zex-10_313.txt EXHIBIT 10.313 REDACTED EXHIBIT 10.313 **CONFIDENTIAL TREATMENT REQUESTED** AMENDMENT This agreement is entered into by and between CHIRON CORPORATION, a Delaware corporation ("Chiron") and GEN-PROBE INCORPORATED, a Delaware corporation ("Gen-Probe"). RECITALS WHEREAS, Chiron and Gen-Probe signed an agreement on June 11, 1998 with respect to Products for the Blood Screening Field and [PROVISION ASSIGNED] (the "Agreement"). WHEREAS, the parties desire to amend the Agreement as set forth in this Amendment in order to facilitate the purposes of the Agreement. AGREEMENT In consideration of the facts recited above and the mutual commitments set forth below, the parties agree as follows: 1. Article 14 of the Agreement shall be and is hereby amended to read as follows: "In consideration for the rights originally granted to Chiron by this Agreement with respect to TMA and HPA, Chiron shall pay to Gen-Probe, [PROVISION ASSIGNED], the following nonrefundable amounts upon the occurrence of each event set forth below: (1) [CONFIDENTIAL TREATMENT REQUESTED]; and (2) [CONFIDENTIAL TREATMENT REQUESTED]: (a) (i) [CONFIDENTIAL TREATMENT REQUESTED] (b) [CONFIDENTIAL TREATMENT REQUESTED]. (3) [CONFIDENTIAL TREATMENT REQUESTED]. (4) [CONFIDENTIAL TREATMENT REQUESTED]. 2. Except as expressly amended above, the Agreement shall remain in full force and effect. By the signatures of their authorized officers below, Gen-Probe and Chiron adopt this amendment as of December 7, 1999. CHIRON CORPORATION GEN-PROBE INCORPORATED By /s/ RAJEN DALAL By /s/ HENRY L. NORDHOFF ---------------- ---------------------- Henry L. Nordhoff Title: President, Blood Testing President and Chiron Chief Executive Officer Page 2 of 2